The 2022 edition will focus on how brand companies help boost the development of IVD industry globally. New technology and innovative ideas will also take centre stage of the show to provide the highest-quality business platform for the whole industry. Furthermore, for 2022 edition, to provide a more flexible way of participation for international companies, remote exhibiting package is offered to allow companies to meet domestic business contacts without traveling long distance. CACLP will showcase the latest innovations from in vitro diagnostic industry via a range of product displays and talks.
In addition, several conferences and forums will run at the Primus Hotel Nanchang International Expo City from 26-28 March, including China IVD Industry Development Conference (CIIDC), China Experimental Medicine Conference (CEMC), Enlightening Lab Med - IVD Youth Entrepreneur Forum (ELMY), China IVD Distribution Enterprise Forum (CIDEF) and China Key Raw Material & Parts Forum (CKRMPF).
The 9th edition of CIIDC is organised by National Association of Health Industry and Enterprises Management, China Association of In Vitro Diagnostics (CAIVD), Shanghai Academy of Experimental Medicine and VIEW journal owned by WILEY. The conference focused on the industrial development, the latest trend, capital operation and business management. Several elites and entrepreneurs in IVD industry discussed about artificial intelligence, business models, international opportunities and others on site.
Organised by National Association of Health Industry and Enterprises Management, Professional Community of Experimental Medicine (PCEM), Shanghai Academy of Experimental Medicine and VIEW journal owned by WILEY, the 7th edition of CEMC will invite academicians, experts and scholars to make reports on the developments of experiment medicine, biomedical engineering, creative medical management and other IVD-relevant topics.
Enlightening Lab Med–the 5th edition of ELMY, the 4th edition of CIDEF and the 2nd edition of CKRMPF will be opened on 25 March, 26 March and 27 March respectively. All above conferences will be complemented by academic seminars: Pathology, Blood Transfusion, Diagnostics, Supervision and over 100 business thematic activities.
Meanwhile, the online and live events have been designed to allow participants to use their time more effectively and efficiently through CACLP. The online platform will be available for a month after the event to allow visitors to continue in acquiring information and making connections within the in vitro diagnostic industry.
For more information, please visit: https://en.caclp.com
About GL events
GL events, whose HQ locates in Lyon, was founded in 1978. It is listed on Euronext Paris, Segment B. The core business of GL events covers 3 business segments, i.e. VENUES (venue management), EXHIBITIONS (exhibition organization) and LIVE (consulting, design and services for events). Through its wide global network of more than 90 offices, with 359 proprietary exhibitions and events, managing 50 venues and serving 4,200 events, GL events is a critical force for city promotion of 27 MICE destinations. GL events reported consolidated annual revenue of over �1.1 billion for 2019, which ranked a leading position in the industry.
About CACLP
CACLP is committed to building a large platform of production, learning, research, application, education, management and service, which integrates academic exchange, industry forum, sharing innovation and exhibition. CACLP has always followed the belief and tenet of CACLP to serve the IVD industry sincerely, promote the continuous progress of IVD industry, promote the communication and cooperation between IVD industry, improve the cooperation with international IVD industry, and establish equal communication and cooperation with laboratory medicine experts, experimental medicine experts and IVD entrepreneurs.
Contact for press:
Ms. Tiki WANG
Tel: +86 21 5255 8215
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.